Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:multiple sclerosis impact scale version 2 questionnaire'
(id=6890142 ; fe=en:multiple sclerosis impact scale version 2 questionnaire ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=3260 creation date=2017-06-25 touchdate=2024-09-18 19:42:34.000)
≈ 129 relations sortantes

  1. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 43 / 1 -> en:fact-p questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fact-p questionnaire | rel=r_associated | relid=0 | w=43
  2. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 36 / 0.837 -> en:fact-g questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fact-g questionnaire | rel=r_associated | relid=0 | w=36
  3. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 35 / 0.814 -> en:activities of daily living dimension of functioning questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:activities of daily living dimension of functioning questionnaire | rel=r_associated | relid=0 | w=35
  4. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 35 / 0.814 -> en:arizona sexual experiences scale-male version questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:arizona sexual experiences scale-male version questionnaire | rel=r_associated | relid=0 | w=35
  5. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 35 / 0.814 -> en:breast cancer prevention trial symptom scales
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:breast cancer prevention trial symptom scales | rel=r_associated | relid=0 | w=35
  6. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 35 / 0.814 -> en:child health questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:child health questionnaire | rel=r_associated | relid=0 | w=35
  7. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 35 / 0.814 -> en:columbia-suicide severity rating scale children's baseline questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:columbia-suicide severity rating scale children's baseline questionnaire | rel=r_associated | relid=0 | w=35
  8. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 35 / 0.814 -> en:columbia-suicide severity rating scale lifetime/recent version questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:columbia-suicide severity rating scale lifetime/recent version questionnaire | rel=r_associated | relid=0 | w=35
  9. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 35 / 0.814 -> en:fact-an questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fact-an questionnaire | rel=r_associated | relid=0 | w=35
  10. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 35 / 0.814 -> en:fact-cns questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fact-cns questionnaire | rel=r_associated | relid=0 | w=35
  11. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 35 / 0.814 -> en:fact-en questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fact-en questionnaire | rel=r_associated | relid=0 | w=35
  12. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 35 / 0.814 -> en:fact-l questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fact-l questionnaire | rel=r_associated | relid=0 | w=35
  13. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 35 / 0.814 -> en:health assessment questionnaire-ii
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:health assessment questionnaire-ii | rel=r_associated | relid=0 | w=35
  14. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 35 / 0.814 -> en:hearing handicap inventory for the elderly, screening version
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:hearing handicap inventory for the elderly, screening version | rel=r_associated | relid=0 | w=35
  15. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 34 / 0.791 -> en:asthma quality of life questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:asthma quality of life questionnaire | rel=r_associated | relid=0 | w=34
  16. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 34 / 0.791 -> en:california verbal learning test - second edition
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:california verbal learning test - second edition | rel=r_associated | relid=0 | w=34
  17. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 34 / 0.791 -> en:cancer rehabilitation evaluation system for research
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:cancer rehabilitation evaluation system for research | rel=r_associated | relid=0 | w=34
  18. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 34 / 0.791 -> en:clinical dementia rating questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:clinical dementia rating questionnaire | rel=r_associated | relid=0 | w=34
  19. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 34 / 0.791 -> en:columbia-suicide severity rating scale baseline questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:columbia-suicide severity rating scale baseline questionnaire | rel=r_associated | relid=0 | w=34
  20. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 34 / 0.791 -> en:columbia-suicide severity rating scale pediatric/cognitively impaired - since last visit - clinical questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:columbia-suicide severity rating scale pediatric/cognitively impaired - since last visit - clinical questionnaire | rel=r_associated | relid=0 | w=34
  21. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 34 / 0.791 -> en:craig handicap assessment and reporting technique-short form interview version questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:craig handicap assessment and reporting technique-short form interview version questionnaire | rel=r_associated | relid=0 | w=34
  22. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 34 / 0.791 -> en:fact-cx questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fact-cx questionnaire | rel=r_associated | relid=0 | w=34
  23. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 32 / 0.744 -> en:alzheimer's disease cooperative study-activities of daily living inventory severe dementia questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:alzheimer's disease cooperative study-activities of daily living inventory severe dementia questionnaire | rel=r_associated | relid=0 | w=32
  24. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 32 / 0.744 -> en:borg scale rating of perceived exertion questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:borg scale rating of perceived exertion questionnaire | rel=r_associated | relid=0 | w=32
  25. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 32 / 0.744 -> en:current opioid misuse measure questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:current opioid misuse measure questionnaire | rel=r_associated | relid=0 | w=32
  26. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 32 / 0.744 -> en:epworth sleepiness scale questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:epworth sleepiness scale questionnaire | rel=r_associated | relid=0 | w=32
  27. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 32 / 0.744 -> en:european quality of life five dimension three level youth questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:european quality of life five dimension three level youth questionnaire | rel=r_associated | relid=0 | w=32
  28. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 32 / 0.744 -> en:follow-up embodiment/outcomes questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:follow-up embodiment/outcomes questionnaire | rel=r_associated | relid=0 | w=32
  29. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 32 / 0.744 -> en:functional assessment of multiple sclerosis questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:functional assessment of multiple sclerosis questionnaire | rel=r_associated | relid=0 | w=32
  30. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 32 / 0.744 -> en:generalized anxiety disorder questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:generalized anxiety disorder questionnaire | rel=r_associated | relid=0 | w=32
  31. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 31 / 0.721 -> en:baseline dyspnea index questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:baseline dyspnea index questionnaire | rel=r_associated | relid=0 | w=31
  32. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 31 / 0.721 -> en:breast lymphedema symptom survey
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:breast lymphedema symptom survey | rel=r_associated | relid=0 | w=31
  33. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 31 / 0.721 -> en:charlson comorbidity index chart review version
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:charlson comorbidity index chart review version | rel=r_associated | relid=0 | w=31
  34. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 31 / 0.721 -> en:faact questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:faact questionnaire | rel=r_associated | relid=0 | w=31
  35. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 30 / 0.698 -> en:alzheimer's disease assessment scale-cognitive cdisc version questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:alzheimer's disease assessment scale-cognitive cdisc version questionnaire | rel=r_associated | relid=0 | w=30
  36. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 30 / 0.698 -> en:alzheimer's disease cooperative study activities of daily living inventory questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:alzheimer's disease cooperative study activities of daily living inventory questionnaire | rel=r_associated | relid=0 | w=30
  37. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 30 / 0.698 -> en:asthma control questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:asthma control questionnaire | rel=r_associated | relid=0 | w=30
  38. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 30 / 0.698 -> en:expanded disability rating scale - postacute interview caregiver version questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:expanded disability rating scale - postacute interview caregiver version questionnaire | rel=r_associated | relid=0 | w=30
  39. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 30 / 0.698 -> en:fact-n questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fact-n questionnaire | rel=r_associated | relid=0 | w=30
  40. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 30 / 0.698 -> en:fait-u questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fait-u questionnaire | rel=r_associated | relid=0 | w=30
  41. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 30 / 0.698 -> en:functional assessment of cancer therapy-breast version 4 questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:functional assessment of cancer therapy-breast version 4 questionnaire | rel=r_associated | relid=0 | w=30
  42. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 30 / 0.698 -> en:functional assessment of cancer therapy-ovarian symptom index questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:functional assessment of cancer therapy-ovarian symptom index questionnaire | rel=r_associated | relid=0 | w=30
  43. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 29 / 0.674 -> en:adult hope scale
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:adult hope scale | rel=r_associated | relid=0 | w=29
  44. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 29 / 0.674 -> en:brief pain inventory short form questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:brief pain inventory short form questionnaire | rel=r_associated | relid=0 | w=29
  45. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 29 / 0.674 -> en:columbia-suicide severity rating scale baseline/screening version phase 1 study 1/14/09 questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:columbia-suicide severity rating scale baseline/screening version phase 1 study 1/14/09 questionnaire | rel=r_associated | relid=0 | w=29
  46. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 29 / 0.674 -> en:columbia-suicide severity rating scale screening questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:columbia-suicide severity rating scale screening questionnaire | rel=r_associated | relid=0 | w=29
  47. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 29 / 0.674 -> en:fact-br questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fact-br questionnaire | rel=r_associated | relid=0 | w=29
  48. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 29 / 0.674 -> en:functional activities questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:functional activities questionnaire | rel=r_associated | relid=0 | w=29
  49. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 28 / 0.651 -> en:children's dermatology life quality index questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:children's dermatology life quality index questionnaire | rel=r_associated | relid=0 | w=28
  50. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 28 / 0.651 -> en:clinical copd questionnaire 1 week version
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:clinical copd questionnaire 1 week version | rel=r_associated | relid=0 | w=28
  51. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 28 / 0.651 -> en:clinical opiate withdrawal scale questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:clinical opiate withdrawal scale questionnaire | rel=r_associated | relid=0 | w=28
  52. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 28 / 0.651 -> en:disease steps questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:disease steps questionnaire | rel=r_associated | relid=0 | w=28
  53. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 28 / 0.651 -> en:eastern cooperative oncology group performance status questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:eastern cooperative oncology group performance status questionnaire | rel=r_associated | relid=0 | w=28
  54. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 28 / 0.651 -> en:european quality of life five dimension five level scale questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:european quality of life five dimension five level scale questionnaire | rel=r_associated | relid=0 | w=28
  55. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 28 / 0.651 -> en:expanded prostate cancer index composite
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:expanded prostate cancer index composite | rel=r_associated | relid=0 | w=28
  56. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 28 / 0.651 -> en:expanded prostate cancer index composite for clinical practice questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:expanded prostate cancer index composite for clinical practice questionnaire | rel=r_associated | relid=0 | w=28
  57. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 28 / 0.651 -> en:fact-e questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fact-e questionnaire | rel=r_associated | relid=0 | w=28
  58. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 28 / 0.651 -> en:geriatric depression scale short form questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:geriatric depression scale short form questionnaire | rel=r_associated | relid=0 | w=28
  59. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 28 / 0.651 -> en:healthy volunteer medical history questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:healthy volunteer medical history questionnaire | rel=r_associated | relid=0 | w=28
  60. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 27 / 0.628 -> en:alcohol use disorder identification test alcohol consumption questions questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:alcohol use disorder identification test alcohol consumption questions questionnaire | rel=r_associated | relid=0 | w=27
  61. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 27 / 0.628 -> en:clinical data interchange standards consortium terminology
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:clinical data interchange standards consortium terminology | rel=r_associated | relid=0 | w=27
  62. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 27 / 0.628 -> en:disability assessment for dementia questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:disability assessment for dementia questionnaire | rel=r_associated | relid=0 | w=27
  63. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 27 / 0.628 -> en:fact-bl questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fact-bl questionnaire | rel=r_associated | relid=0 | w=27
  64. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 27 / 0.628 -> en:fact-hep questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fact-hep questionnaire | rel=r_associated | relid=0 | w=27
  65. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 26 / 0.605 -> en:6-item orientation-memory-concentration test
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:6-item orientation-memory-concentration test | rel=r_associated | relid=0 | w=26
  66. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 26 / 0.605 -> en:australia-modified karnofsky performance scale
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:australia-modified karnofsky performance scale | rel=r_associated | relid=0 | w=26
  67. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 26 / 0.605 -> en:borg category-ratio 10 scale questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:borg category-ratio 10 scale questionnaire | rel=r_associated | relid=0 | w=26
  68. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 26 / 0.605 -> en:contemplation ladder for smoking cessation
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:contemplation ladder for smoking cessation | rel=r_associated | relid=0 | w=26
  69. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 26 / 0.605 -> en:fact-bp questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fact-bp questionnaire | rel=r_associated | relid=0 | w=26
  70. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 26 / 0.605 -> en:fact-m questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fact-m questionnaire | rel=r_associated | relid=0 | w=26
  71. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 26 / 0.605 -> en:fact-th11 questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fact-th11 questionnaire | rel=r_associated | relid=0 | w=26
  72. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 26 / 0.605 -> en:functional assessment of chronic illness therapy-fatigue version 4 questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:functional assessment of chronic illness therapy-fatigue version 4 questionnaire | rel=r_associated | relid=0 | w=26
  73. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 25 / 0.581 -> en:multiple
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:multiple | rel=r_associated | relid=0 | w=25
  74. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 21 / 0.488 -> en:cdisc sdtm terminology
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:cdisc sdtm terminology | rel=r_associated | relid=0 | w=21
  75. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:alcohol use disorder identification test self-report version questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:alcohol use disorder identification test self-report version questionnaire | rel=r_associated | relid=0 | w=20
  76. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:alzheimer's disease cooperative study-clinical global impression of change questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:alzheimer's disease cooperative study-clinical global impression of change questionnaire | rel=r_associated | relid=0 | w=20
  77. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:aya-hears
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:aya-hears | rel=r_associated | relid=0 | w=20
  78. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:bladder control scale questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:bladder control scale questionnaire | rel=r_associated | relid=0 | w=20
  79. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:bowel control scale questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:bowel control scale questionnaire | rel=r_associated | relid=0 | w=20
  80. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:breast cancer treatment outcomes scale-cosmetic status
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:breast cancer treatment outcomes scale-cosmetic status | rel=r_associated | relid=0 | w=20
  81. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:brief psychiatric rating scale - version 4
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:brief psychiatric rating scale - version 4 | rel=r_associated | relid=0 | w=20
  82. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:cdisc qrs terminology
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:cdisc qrs terminology | rel=r_associated | relid=0 | w=20
  83. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:cdisc questionnaire terminology
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:cdisc questionnaire terminology | rel=r_associated | relid=0 | w=20
  84. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:center for epidemiologic studies depression scale revised
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:center for epidemiologic studies depression scale revised | rel=r_associated | relid=0 | w=20
  85. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:clinical global impression questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:clinical global impression questionnaire | rel=r_associated | relid=0 | w=20
  86. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:columbia-suicide severity rating scale baseline/screening version questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:columbia-suicide severity rating scale baseline/screening version questionnaire | rel=r_associated | relid=0 | w=20
  87. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:columbia-suicide severity rating scale pediatric/cognitively impaired lifetime/recent questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:columbia-suicide severity rating scale pediatric/cognitively impaired lifetime/recent questionnaire | rel=r_associated | relid=0 | w=20
  88. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:eortc/rotg late radiation morbidity scoring criteria
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:eortc/rotg late radiation morbidity scoring criteria | rel=r_associated | relid=0 | w=20
  89. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:extended glasgow outcome scale questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:extended glasgow outcome scale questionnaire | rel=r_associated | relid=0 | w=20
  90. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:fact-b questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fact-b questionnaire | rel=r_associated | relid=0 | w=20
  91. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:fksi-15 questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:fksi-15 questionnaire | rel=r_associated | relid=0 | w=20
  92. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:hemophilia quality of life questionnaire children's long version age group ii
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:hemophilia quality of life questionnaire children's long version age group ii | rel=r_associated | relid=0 | w=20
  93. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:human activity profile
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:human activity profile | rel=r_associated | relid=0 | w=20
  94. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:impact of visual impairment scale questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:impact of visual impairment scale questionnaire | rel=r_associated | relid=0 | w=20
  95. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:instrumental activities of daily living
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:instrumental activities of daily living | rel=r_associated | relid=0 | w=20
  96. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:md anderson symptom inventory - core
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:md anderson symptom inventory - core | rel=r_associated | relid=0 | w=20
  97. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:modified barium swallow impairment profile
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:modified barium swallow impairment profile | rel=r_associated | relid=0 | w=20
  98. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:myeloproliferative neoplasm symptom assessment form
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:myeloproliferative neoplasm symptom assessment form | rel=r_associated | relid=0 | w=20
  99. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:national comprehensive cancer network/functional assessment of cancer therapy-bladder symptom index-18 version 2 questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-bladder symptom index-18 version 2 questionnaire | rel=r_associated | relid=0 | w=20
  100. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20
  101. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:national comprehensive cancer network/functional assessment of cancer therapy-ovarian symptom index-18 version 2 questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-ovarian symptom index-18 version 2 questionnaire | rel=r_associated | relid=0 | w=20
  102. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:neuropsychiatric inventory questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:neuropsychiatric inventory questionnaire | rel=r_associated | relid=0 | w=20
  103. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:ocular comfort index questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:ocular comfort index questionnaire | rel=r_associated | relid=0 | w=20
  104. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:older americans resources and services comorbidity scale
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:older americans resources and services comorbidity scale | rel=r_associated | relid=0 | w=20
  105. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:osoba nausea and emesis module
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:osoba nausea and emesis module | rel=r_associated | relid=0 | w=20
  106. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:outcome satisfaction questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:outcome satisfaction questionnaire | rel=r_associated | relid=0 | w=20
  107. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:patient health questionnaire - 9 item
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:patient health questionnaire - 9 item | rel=r_associated | relid=0 | w=20
  108. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:patient reported outcomes version of ctcae
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:patient reported outcomes version of ctcae | rel=r_associated | relid=0 | w=20
  109. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:primary care evaluation of mental disorders patient health questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:primary care evaluation of mental disorders patient health questionnaire | rel=r_associated | relid=0 | w=20
  110. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:quality of life questionnaire - gastrointestinal neuroendocrine tumors 21
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:quality of life questionnaire - gastrointestinal neuroendocrine tumors 21 | rel=r_associated | relid=0 | w=20
  111. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:quality of life questionnaire-multiple myeloma 20
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:quality of life questionnaire-multiple myeloma 20 | rel=r_associated | relid=0 | w=20
  112. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:revised fibromyalgia impact questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=20
  113. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:satisfaction with life scale questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:satisfaction with life scale questionnaire | rel=r_associated | relid=0 | w=20
  114. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:short-form mcgill pain questionnaire-2
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:short-form mcgill pain questionnaire-2 | rel=r_associated | relid=0 | w=20
  115. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:shortness of breath with daily activities questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:shortness of breath with daily activities questionnaire | rel=r_associated | relid=0 | w=20
  116. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:smoking self-efficacy questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:smoking self-efficacy questionnaire | rel=r_associated | relid=0 | w=20
  117. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:st. george's respiratory questionnaire past 3 months version
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:st. george's respiratory questionnaire past 3 months version | rel=r_associated | relid=0 | w=20
  118. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:subjective numeracy scale
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:subjective numeracy scale | rel=r_associated | relid=0 | w=20
  119. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:subjective opiate withdrawal scale questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:subjective opiate withdrawal scale questionnaire | rel=r_associated | relid=0 | w=20
  120. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:taps tool - interviewer version
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:taps tool - interviewer version | rel=r_associated | relid=0 | w=20
  121. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:the expanded prostate cancer index composite short form questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:the expanded prostate cancer index composite short form questionnaire | rel=r_associated | relid=0 | w=20
  122. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:university of washington quality of life scale, version 4
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:university of washington quality of life scale, version 4 | rel=r_associated | relid=0 | w=20
  123. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:visual functioning questionnaire 25-interviewer administered format version 2000
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:visual functioning questionnaire 25-interviewer administered format version 2000 | rel=r_associated | relid=0 | w=20
  124. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:wechsler memory scale - fourth edition
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:wechsler memory scale - fourth edition | rel=r_associated | relid=0 | w=20
  125. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:western ontario and mcmaster universities osteoarthritis index version 3.1 likert scale format questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:western ontario and mcmaster universities osteoarthritis index version 3.1 likert scale format questionnaire | rel=r_associated | relid=0 | w=20
  126. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:western ontario and mcmaster universities osteoarthritis index version 3.1 visual analog scale format questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:western ontario and mcmaster universities osteoarthritis index version 3.1 visual analog scale format questionnaire | rel=r_associated | relid=0 | w=20
  127. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:woodcock-johnson tests of cognitive abilities
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:woodcock-johnson tests of cognitive abilities | rel=r_associated | relid=0 | w=20
  128. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:work limitations questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:work limitations questionnaire | rel=r_associated | relid=0 | w=20
  129. en:multiple sclerosis impact scale version 2 questionnaire -- r_associated #0: 20 / 0.465 -> en:work productivity and activity impairment general health v2.0 questionnaire
    n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:work productivity and activity impairment general health v2.0 questionnaire | rel=r_associated | relid=0 | w=20
≈ 128 relations entrantes

  1. en:columbia-suicide severity rating scale baseline/screening version questionnaire --- r_associated #0: 42 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:columbia-suicide severity rating scale baseline/screening version questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=42
  2. en:wechsler memory scale - fourth edition --- r_associated #0: 40 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:wechsler memory scale - fourth edition | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=40
  3. en:functional assessment of cancer therapy-breast version 4 questionnaire --- r_associated #0: 36 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:functional assessment of cancer therapy-breast version 4 questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=36
  4. en:outcome satisfaction questionnaire --- r_associated #0: 36 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:outcome satisfaction questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=36
  5. en:shortness of breath with daily activities questionnaire --- r_associated #0: 35 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:shortness of breath with daily activities questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=35
  6. en:work productivity and activity impairment general health v2.0 questionnaire --- r_associated #0: 35 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:work productivity and activity impairment general health v2.0 questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=35
  7. en:clinical global impression questionnaire --- r_associated #0: 34 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:clinical global impression questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=34
  8. en:fksi-15 questionnaire --- r_associated #0: 34 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fksi-15 questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=34
  9. en:hemophilia quality of life questionnaire children's long version age group ii --- r_associated #0: 34 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:hemophilia quality of life questionnaire children's long version age group ii | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=34
  10. en:modified barium swallow impairment profile --- r_associated #0: 34 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:modified barium swallow impairment profile | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=34
  11. en:neuropsychiatric inventory questionnaire --- r_associated #0: 34 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:neuropsychiatric inventory questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=34
  12. en:patient reported outcomes version of ctcae --- r_associated #0: 34 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:patient reported outcomes version of ctcae | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=34
  13. en:primary care evaluation of mental disorders patient health questionnaire --- r_associated #0: 34 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:primary care evaluation of mental disorders patient health questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=34
  14. en:revised fibromyalgia impact questionnaire --- r_associated #0: 34 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:revised fibromyalgia impact questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=34
  15. en:borg scale rating of perceived exertion questionnaire --- r_associated #0: 32 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:borg scale rating of perceived exertion questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=32
  16. en:clinical data interchange standards consortium terminology --- r_associated #0: 32 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:clinical data interchange standards consortium terminology | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=32
  17. en:eortc/rotg late radiation morbidity scoring criteria --- r_associated #0: 32 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:eortc/rotg late radiation morbidity scoring criteria | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=32
  18. en:satisfaction with life scale questionnaire --- r_associated #0: 32 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:satisfaction with life scale questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=32
  19. en:visual functioning questionnaire 25-interviewer administered format version 2000 --- r_associated #0: 32 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:visual functioning questionnaire 25-interviewer administered format version 2000 | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=32
  20. en:aya-hears --- r_associated #0: 31 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:aya-hears | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=31
  21. en:bladder control scale questionnaire --- r_associated #0: 31 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:bladder control scale questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=31
  22. en:fact-b questionnaire --- r_associated #0: 31 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fact-b questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=31
  23. en:functional assessment of cancer therapy-ovarian symptom index questionnaire --- r_associated #0: 31 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:functional assessment of cancer therapy-ovarian symptom index questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=31
  24. en:short-form mcgill pain questionnaire-2 --- r_associated #0: 31 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:short-form mcgill pain questionnaire-2 | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=31
  25. en:smoking self-efficacy questionnaire --- r_associated #0: 31 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:smoking self-efficacy questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=31
  26. en:subjective opiate withdrawal scale questionnaire --- r_associated #0: 31 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:subjective opiate withdrawal scale questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=31
  27. en:the expanded prostate cancer index composite short form questionnaire --- r_associated #0: 31 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:the expanded prostate cancer index composite short form questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=31
  28. en:university of washington quality of life scale, version 4 --- r_associated #0: 31 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:university of washington quality of life scale, version 4 | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=31
  29. en:western ontario and mcmaster universities osteoarthritis index version 3.1 likert scale format questionnaire --- r_associated #0: 31 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:western ontario and mcmaster universities osteoarthritis index version 3.1 likert scale format questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=31
  30. en:brief pain inventory short form questionnaire --- r_associated #0: 30 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:brief pain inventory short form questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=30
  31. en:extended glasgow outcome scale questionnaire --- r_associated #0: 30 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:extended glasgow outcome scale questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=30
  32. en:instrumental activities of daily living --- r_associated #0: 30 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:instrumental activities of daily living | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=30
  33. en:st. george's respiratory questionnaire past 3 months version --- r_associated #0: 30 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:st. george's respiratory questionnaire past 3 months version | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=30
  34. en:alcohol use disorder identification test self-report version questionnaire --- r_associated #0: 29 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:alcohol use disorder identification test self-report version questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=29
  35. en:clinical dementia rating questionnaire --- r_associated #0: 29 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:clinical dementia rating questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=29
  36. en:columbia-suicide severity rating scale pediatric/cognitively impaired lifetime/recent questionnaire --- r_associated #0: 29 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:columbia-suicide severity rating scale pediatric/cognitively impaired lifetime/recent questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=29
  37. en:expanded prostate cancer index composite for clinical practice questionnaire --- r_associated #0: 29 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:expanded prostate cancer index composite for clinical practice questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=29
  38. en:patient health questionnaire - 9 item --- r_associated #0: 29 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:patient health questionnaire - 9 item | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=29
  39. en:woodcock-johnson tests of cognitive abilities --- r_associated #0: 29 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:woodcock-johnson tests of cognitive abilities | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=29
  40. en:adult hope scale --- r_associated #0: 28 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:adult hope scale | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=28
  41. en:brief psychiatric rating scale - version 4 --- r_associated #0: 28 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:brief psychiatric rating scale - version 4 | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=28
  42. en:cdisc questionnaire terminology --- r_associated #0: 28 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:cdisc questionnaire terminology | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=28
  43. en:center for epidemiologic studies depression scale revised --- r_associated #0: 28 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:center for epidemiologic studies depression scale revised | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=28
  44. en:hearing handicap inventory for the elderly, screening version --- r_associated #0: 28 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:hearing handicap inventory for the elderly, screening version | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=28
  45. en:quality of life questionnaire - gastrointestinal neuroendocrine tumors 21 --- r_associated #0: 28 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:quality of life questionnaire - gastrointestinal neuroendocrine tumors 21 | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=28
  46. en:subjective numeracy scale --- r_associated #0: 28 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:subjective numeracy scale | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=28
  47. en:alzheimer's disease cooperative study-clinical global impression of change questionnaire --- r_associated #0: 27 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:alzheimer's disease cooperative study-clinical global impression of change questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=27
  48. en:bowel control scale questionnaire --- r_associated #0: 27 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:bowel control scale questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=27
  49. en:cdisc qrs terminology --- r_associated #0: 27 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:cdisc qrs terminology | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=27
  50. en:child health questionnaire --- r_associated #0: 27 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:child health questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=27
  51. en:md anderson symptom inventory - core --- r_associated #0: 27 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:md anderson symptom inventory - core | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=27
  52. en:taps tool - interviewer version --- r_associated #0: 27 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:taps tool - interviewer version | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=27
  53. en:western ontario and mcmaster universities osteoarthritis index version 3.1 visual analog scale format questionnaire --- r_associated #0: 27 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:western ontario and mcmaster universities osteoarthritis index version 3.1 visual analog scale format questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=27
  54. en:breast cancer treatment outcomes scale-cosmetic status --- r_associated #0: 26 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:breast cancer treatment outcomes scale-cosmetic status | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=26
  55. en:cdisc sdtm terminology --- r_associated #0: 26 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:cdisc sdtm terminology | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=26
  56. en:columbia-suicide severity rating scale pediatric/cognitively impaired - since last visit - clinical questionnaire --- r_associated #0: 26 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:columbia-suicide severity rating scale pediatric/cognitively impaired - since last visit - clinical questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=26
  57. en:fact-n questionnaire --- r_associated #0: 26 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fact-n questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=26
  58. en:human activity profile --- r_associated #0: 26 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:human activity profile | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=26
  59. en:impact of visual impairment scale questionnaire --- r_associated #0: 26 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:impact of visual impairment scale questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=26
  60. en:myeloproliferative neoplasm symptom assessment form --- r_associated #0: 26 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:myeloproliferative neoplasm symptom assessment form | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=26
  61. en:national comprehensive cancer network/functional assessment of cancer therapy-bladder symptom index-18 version 2 questionnaire --- r_associated #0: 26 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:national comprehensive cancer network/functional assessment of cancer therapy-bladder symptom index-18 version 2 questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=26
  62. en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire --- r_associated #0: 26 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=26
  63. en:national comprehensive cancer network/functional assessment of cancer therapy-ovarian symptom index-18 version 2 questionnaire --- r_associated #0: 26 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:national comprehensive cancer network/functional assessment of cancer therapy-ovarian symptom index-18 version 2 questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=26
  64. en:ocular comfort index questionnaire --- r_associated #0: 26 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:ocular comfort index questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=26
  65. en:older americans resources and services comorbidity scale --- r_associated #0: 26 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:older americans resources and services comorbidity scale | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=26
  66. en:osoba nausea and emesis module --- r_associated #0: 26 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:osoba nausea and emesis module | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=26
  67. en:quality of life questionnaire-multiple myeloma 20 --- r_associated #0: 26 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:quality of life questionnaire-multiple myeloma 20 | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=26
  68. en:work limitations questionnaire --- r_associated #0: 26 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:work limitations questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=26
  69. en:6-item orientation-memory-concentration test --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:6-item orientation-memory-concentration test | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  70. en:activities of daily living dimension of functioning questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:activities of daily living dimension of functioning questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  71. en:alcohol use disorder identification test alcohol consumption questions questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:alcohol use disorder identification test alcohol consumption questions questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  72. en:alzheimer's disease assessment scale-cognitive cdisc version questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:alzheimer's disease assessment scale-cognitive cdisc version questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  73. en:alzheimer's disease cooperative study activities of daily living inventory questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:alzheimer's disease cooperative study activities of daily living inventory questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  74. en:alzheimer's disease cooperative study-activities of daily living inventory severe dementia questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:alzheimer's disease cooperative study-activities of daily living inventory severe dementia questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  75. en:arizona sexual experiences scale-male version questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:arizona sexual experiences scale-male version questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  76. en:asthma control questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:asthma control questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  77. en:asthma quality of life questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:asthma quality of life questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  78. en:australia-modified karnofsky performance scale --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:australia-modified karnofsky performance scale | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  79. en:baseline dyspnea index questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:baseline dyspnea index questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  80. en:borg category-ratio 10 scale questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:borg category-ratio 10 scale questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  81. en:breast cancer prevention trial symptom scales --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:breast cancer prevention trial symptom scales | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  82. en:breast lymphedema symptom survey --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:breast lymphedema symptom survey | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  83. en:california verbal learning test - second edition --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:california verbal learning test - second edition | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  84. en:cancer rehabilitation evaluation system for research --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:cancer rehabilitation evaluation system for research | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  85. en:charlson comorbidity index chart review version --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:charlson comorbidity index chart review version | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  86. en:children's dermatology life quality index questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:children's dermatology life quality index questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  87. en:clinical copd questionnaire 1 week version --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:clinical copd questionnaire 1 week version | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  88. en:clinical opiate withdrawal scale questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:clinical opiate withdrawal scale questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  89. en:columbia-suicide severity rating scale baseline questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:columbia-suicide severity rating scale baseline questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  90. en:columbia-suicide severity rating scale baseline/screening version phase 1 study 1/14/09 questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:columbia-suicide severity rating scale baseline/screening version phase 1 study 1/14/09 questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  91. en:columbia-suicide severity rating scale children's baseline questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:columbia-suicide severity rating scale children's baseline questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  92. en:columbia-suicide severity rating scale lifetime/recent version questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:columbia-suicide severity rating scale lifetime/recent version questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  93. en:columbia-suicide severity rating scale screening questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:columbia-suicide severity rating scale screening questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  94. en:contemplation ladder for smoking cessation --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:contemplation ladder for smoking cessation | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  95. en:craig handicap assessment and reporting technique-short form interview version questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:craig handicap assessment and reporting technique-short form interview version questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  96. en:current opioid misuse measure questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:current opioid misuse measure questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  97. en:disability assessment for dementia questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:disability assessment for dementia questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  98. en:disease steps questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:disease steps questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  99. en:eastern cooperative oncology group performance status questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:eastern cooperative oncology group performance status questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  100. en:epworth sleepiness scale questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:epworth sleepiness scale questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  101. en:european quality of life five dimension five level scale questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:european quality of life five dimension five level scale questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  102. en:european quality of life five dimension three level youth questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:european quality of life five dimension three level youth questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  103. en:expanded disability rating scale - postacute interview caregiver version questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:expanded disability rating scale - postacute interview caregiver version questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  104. en:expanded prostate cancer index composite --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:expanded prostate cancer index composite | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  105. en:faact questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:faact questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  106. en:fact-an questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fact-an questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  107. en:fact-bl questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fact-bl questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  108. en:fact-bp questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fact-bp questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  109. en:fact-br questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fact-br questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  110. en:fact-cns questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fact-cns questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  111. en:fact-cx questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fact-cx questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  112. en:fact-e questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fact-e questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  113. en:fact-en questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fact-en questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  114. en:fact-g questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fact-g questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  115. en:fact-hep questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fact-hep questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  116. en:fact-l questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fact-l questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  117. en:fact-m questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fact-m questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  118. en:fact-p questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fact-p questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  119. en:fact-th11 questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fact-th11 questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  120. en:fait-u questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:fait-u questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  121. en:follow-up embodiment/outcomes questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:follow-up embodiment/outcomes questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  122. en:functional activities questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:functional activities questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  123. en:functional assessment of chronic illness therapy-fatigue version 4 questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:functional assessment of chronic illness therapy-fatigue version 4 questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  124. en:functional assessment of multiple sclerosis questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:functional assessment of multiple sclerosis questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  125. en:generalized anxiety disorder questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:generalized anxiety disorder questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  126. en:geriatric depression scale short form questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:geriatric depression scale short form questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  127. en:health assessment questionnaire-ii --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:health assessment questionnaire-ii | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
  128. en:healthy volunteer medical history questionnaire --- r_associated #0: 20 --> en:multiple sclerosis impact scale version 2 questionnaire
    n1=en:healthy volunteer medical history questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=20
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr